Your Link to Better Therapies
Xgene Pharmaceutical Inc. is an international, venture capital-backed company in the late stages of clinical development. We specialize in development of innovative, multimodal conjugated molecules powered by our proprietary technology. Our focus is dedicated to transforming the treatment landscape of neurological disorders by simultaneously targeting the multifaceted dimensions of pain. These include neuropathic, nociceptive, craniofacial, central sensitization and mixed pain mechanisms. We aim to advance pain therapies that offer outstanding efficacy and excellent tolerability.